NO995692L - Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse i terapi - Google Patents
Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse i terapiInfo
- Publication number
- NO995692L NO995692L NO995692A NO995692A NO995692L NO 995692 L NO995692 L NO 995692L NO 995692 A NO995692 A NO 995692A NO 995692 A NO995692 A NO 995692A NO 995692 L NO995692 L NO 995692L
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- novel
- preparation
- protective activity
- organ protective
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 230000002669 organ and tissue protective effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97108384 | 1997-05-23 | ||
| PCT/EP1998/002953 WO1998052973A1 (en) | 1997-05-23 | 1998-05-20 | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO995692D0 NO995692D0 (no) | 1999-11-19 |
| NO995692L true NO995692L (no) | 2000-01-24 |
| NO321126B1 NO321126B1 (no) | 2006-03-20 |
Family
ID=8226822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19995692A NO321126B1 (no) | 1997-05-23 | 1999-11-19 | Salt av et BPC (Body protection compound) "kroppsbeskyttelsesforbindelse"-peptid, omfattende 8 aminosyrerester, kompatibelt, lagringsstabilt, farmasoytisk preparat, diagnostisk lagringsstabilt preparat, anvendelser og fremgangsmater derav. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6288028B1 (no) |
| EP (1) | EP0983300B1 (no) |
| JP (1) | JP3492381B2 (no) |
| KR (1) | KR100488038B1 (no) |
| CN (1) | CN1166683C (no) |
| AR (1) | AR011478A1 (no) |
| AT (1) | ATE277948T1 (no) |
| AU (1) | AU731317B2 (no) |
| BG (1) | BG64023B1 (no) |
| BR (1) | BR9809457B1 (no) |
| CA (1) | CA2290739C (no) |
| CZ (1) | CZ299423B6 (no) |
| DE (1) | DE69826653T2 (no) |
| DK (1) | DK0983300T3 (no) |
| EA (1) | EA002058B1 (no) |
| ES (1) | ES2229507T3 (no) |
| HU (1) | HU227800B1 (no) |
| ID (1) | ID23184A (no) |
| IL (2) | IL132884A0 (no) |
| NO (1) | NO321126B1 (no) |
| NZ (1) | NZ501323A (no) |
| PL (1) | PL193790B1 (no) |
| PT (1) | PT983300E (no) |
| RS (1) | RS49733B (no) |
| SK (1) | SK159599A3 (no) |
| TR (1) | TR199902866T2 (no) |
| UA (1) | UA61955C2 (no) |
| WO (1) | WO1998052973A1 (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4912875B2 (ja) * | 2004-02-27 | 2012-04-11 | 不二製油株式会社 | 癌転移抑制組成物 |
| US8022216B2 (en) * | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| SI24318A (sl) | 2013-03-13 | 2014-09-30 | Diagen D.O.O. | Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji |
| US10350293B2 (en) | 2016-08-23 | 2019-07-16 | Pharmacotherapia d.o.o. | Compositions and methods for treating symptoms associated with multiple sclerosis |
| HRP20240485T1 (hr) | 2017-08-24 | 2024-07-05 | Novo Nordisk A/S | Pripravci glp-1 i njihova upotreba |
| PE20230819A1 (es) | 2020-02-18 | 2023-05-19 | Novo Nordisk As | Composiciones y usos de glp-1 |
| US11065298B1 (en) * | 2020-04-24 | 2021-07-20 | Chanda Zaveri | Compositions and methods for treating or preventing viral infections |
| US12605427B2 (en) * | 2023-05-15 | 2026-04-21 | Red Mountain Med Spa, LLC | Sublingual semaglutide-BPC 157 combination for weight loss |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992004368A1 (en) * | 1990-09-11 | 1992-03-19 | Sikiric Predrag | Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
| ATE152734T1 (de) * | 1992-05-30 | 1997-05-15 | Sikiric Predrag | Bpc-peptide, deren herstellung und verwendung |
| EP0624164B1 (en) * | 1992-11-16 | 1998-02-11 | Marijan Mr.Sc. Petek | Peptides with organo-protective activity, process for their preparation and their use in the therapy |
-
1998
- 1998-05-20 DE DE69826653T patent/DE69826653T2/de not_active Expired - Lifetime
- 1998-05-20 AT AT98929345T patent/ATE277948T1/de active
- 1998-05-20 EP EP98929345A patent/EP0983300B1/en not_active Expired - Lifetime
- 1998-05-20 CZ CZ0414299A patent/CZ299423B6/cs not_active IP Right Cessation
- 1998-05-20 HU HU0002329A patent/HU227800B1/hu not_active IP Right Cessation
- 1998-05-20 CN CNB988053934A patent/CN1166683C/zh not_active Expired - Fee Related
- 1998-05-20 CA CA002290739A patent/CA2290739C/en not_active Expired - Fee Related
- 1998-05-20 SK SK1595-99A patent/SK159599A3/sk unknown
- 1998-05-20 US US09/424,414 patent/US6288028B1/en not_active Expired - Lifetime
- 1998-05-20 KR KR10-1999-7010862A patent/KR100488038B1/ko not_active Expired - Fee Related
- 1998-05-20 PT PT98929345T patent/PT983300E/pt unknown
- 1998-05-20 JP JP54994898A patent/JP3492381B2/ja not_active Expired - Fee Related
- 1998-05-20 ID IDW991444A patent/ID23184A/id unknown
- 1998-05-20 RS YUP-601/99A patent/RS49733B/sr unknown
- 1998-05-20 ES ES98929345T patent/ES2229507T3/es not_active Expired - Lifetime
- 1998-05-20 PL PL98336897A patent/PL193790B1/pl unknown
- 1998-05-20 NZ NZ501323A patent/NZ501323A/en not_active IP Right Cessation
- 1998-05-20 TR TR1999/02866T patent/TR199902866T2/xx unknown
- 1998-05-20 UA UA99127002A patent/UA61955C2/uk unknown
- 1998-05-20 WO PCT/EP1998/002953 patent/WO1998052973A1/en not_active Ceased
- 1998-05-20 AU AU79141/98A patent/AU731317B2/en not_active Ceased
- 1998-05-20 IL IL13288498A patent/IL132884A0/xx active IP Right Grant
- 1998-05-20 EA EA199901061A patent/EA002058B1/ru not_active IP Right Cessation
- 1998-05-20 DK DK98929345T patent/DK0983300T3/da active
- 1998-05-20 BR BRPI9809457-2A patent/BR9809457B1/pt not_active IP Right Cessation
- 1998-05-26 AR ARP980102425A patent/AR011478A1/es active IP Right Grant
-
1999
- 1999-11-11 IL IL132884A patent/IL132884A/en not_active IP Right Cessation
- 1999-11-19 BG BG103905A patent/BG64023B1/bg unknown
- 1999-11-19 NO NO19995692A patent/NO321126B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO985977D0 (no) | Spiro-piperidinderivater og deres anvendelse som terapeutiske midler | |
| DK476089A (da) | Terapeutisk aktive forbindelser og deres fremstilling | |
| DK0869126T3 (da) | Dithiolanderivater, deres fremstilling og deres terapeutiske virkning | |
| DK273689A (da) | 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler | |
| NO943682D0 (no) | Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse | |
| NO991761D0 (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| EP1206270A4 (en) | CERAMID AND CHEMOTHERAPEUTIC AGENTS INDUCING APOPTOSIS | |
| FI955906A7 (fi) | O6-substituoituja guaniinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö kasvainsolujen hoidossa | |
| NO975020D0 (no) | Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi | |
| NO995692L (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse i terapi | |
| NO20000462D0 (no) | 4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid derivater, deres fremstilling og deres anvendelse i terapi | |
| NO992676D0 (no) | 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse | |
| NO962477L (no) | Benzamidderivater, deres fremstilling og deres terapautiske anvendelse | |
| NO984624D0 (no) | Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav | |
| DK26589A (da) | Aminosyreglycerider og fysiologisk acceptable salte deraf med syrer og baser, deres fremstilling og anvendelse | |
| DK291886A (da) | 1,8-broforbundne 4-quinolon-3-carboxylsyrer, deres fremstilling og anvendelse i laegemidler og dyrefoder | |
| NO991581D0 (no) | N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler | |
| DK222488A (da) | Glycopeptider med enkephalinase-haemmende virkning,deres fremstilling og anvendelse | |
| DK578789D0 (da) | Pyrrolidin-2-carboxylsyre-derivater med psykotrop virkning, deres fremstilling og anvendelse | |
| DK360189A (da) | S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse | |
| DK51789A (da) | Aminosyreamider, deres fremstilling og anvendelse | |
| NO955242D0 (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse | |
| DK489889A (da) | Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler | |
| NO20023015L (no) | Humant heparanasebeslektet polypeptid og nukleinsyre | |
| NO990303L (no) | Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |